Contraceptives Market Size Report | Share & Forecast 2028

Contraceptives Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product [Condoms, Intrauterine Product (IUDs), Vaginal Rings, Implants, Patches, Diaphragms, Emergency Contraceptives, Sponges, Others], End User (Home Care, Hospitals and Clinics), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospital Pharmacy)

Publication Month : Mar 2021

  • Report Code : TIPHE100001405
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 227
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The contraceptives market size is expected to grow from US$ 20,825.0 million in 2020 and is expected to reach US$ 29,629.4 million by 2028; it is estimated to record a CAGR of 4.6% from 2021 to 2028.

Analyst Perspective:

The rising prevalence of sexually transmitted diseases and the growing need for population control is expected to grow at a lucrative rate over the forecast period. Implementing initiatives to curb unwanted pregnancies associated with healthcare expenditure and the subsequent growth in user awareness levels are expected to boost the contraceptive market over the forecast period. Moreover, health issues associated with teenage pregnancies, an increase in awareness of modern contraception, and a rise in the use of oral pills as a key method to avoid unplanned pregnancy further boots the Contraceptives Market growth. Various key players such as Cooper Surgical, Veru Inc., Pfizer Inc., and others are adopting the acquisition strategy to enhance their product portfolio and maintain market competition. For instance, in March 2021, Cooper acquired a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth, which is expected to provide a contraceptive market opportunity.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Contraceptives Market: Strategic Insights

contraceptives-market
Market Size Value inUS$ 20,825.0 million in 2020
Market Size Value byUS$ 29,629.4 million by 2028
Growth rateCAGR of 4.6% from 2021 to 2028
Forecast Period2021-2028
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Overview:

Contraception is defined as the intentional prevention of conception through the use of various devices, sexual practices, chemicals, drugs, or surgical procedures. Thus, any device or act whose purpose is to prevent a woman from becoming pregnant can be considered as a contraceptive. Contraceptives prevent pregnancy by preventing sperm from entering the uterus. It is more commonly known as the birth control method used to avoid pregnancy. Various contraceptive methods are available in the market, such as male condoms, female condoms, IUDs, vaginal rings, diaphragms, and contracepti0076e sponges. However, condoms are the only contraceptive product that prevents sexually transmitted infections (STI). One of the market's primary drivers is the need to avoid unwanted pregnancies, particularly in teenage women. Also, rising government efforts to promote family planning and prevent unwanted pregnancy is contributing to the growth of the market.

Lucrative Regions for Contraceptives Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Driver:

Increasing Rate of Unwanted Pregnancies to Drive Growth of Contraceptives Market

A large percentage of unintended pregnancies results from not using contraception or using it non-consistently or incorrectly. The increasing need to prevent such unwanted pregnancies, particularly in teenage women, is one of the primary drivers of the contraceptives market. The rate of such pregnancy cases is highest among women in low-income countries. For instance, as per the World Health Organization (WHO), ~74 million women in low- and middle-income countries have unintended pregnancies every year, resulting in 25 million unsafe abortions and 47,000 maternal deaths. Unintended pregnancies may lead to malnutrition, illness, abuse, and neglect, as well as death in the worst case, among mothers and newborns. They can further lead to lower educational and employment potential and poverty. Despite advancements in technology, teen pregnancy rate is substantially higher in the US than in other western countries. As per DoSomething.org, out of 3 in 10 American teen girls get pregnant at least once before age 20, thus accounting for ~750,000 teen pregnancies every year. Parenthood is one of the leading reasons compelling teen girls to drop out of schools, and ~50% of teen girls do not graduate from high schools due to motherhood. Such issues can be addressed by extending access to contraceptives. A wide range of birth control methods such as condoms, intrauterine devices (IUDs), and birth control pills are available. As per the WHO, the modern methods of contraception have a vital role in preventing unintended pregnancies. Therefore, increased access to contraceptives as well as family planning information and services results in fewer pregnancy and childbirth deaths, unintended pregnancies, abortions, and infant deaths.

Segmental Analysis:

Based on product, the contraceptives market is segmented into condoms, intrauterine product (IUDs), vaginal rings, implants, patches, diaphragms, emergency contraceptives, sponges, and others. The condoms segment held the largest share of the market in 2020, whereas the intrauterine product (IUDs) segment is anticipated to register the highest CAGR in the market during the forecast period. Rising awareness about STDs and HIV has led to an increase in the usage of condoms globally. Currently, both male and female condoms are commercially available. Condoms reduce the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. Male condoms are 98% effective, and around 12% of women will still get pregnant because the condoms are not used properly. Female condoms are 95% effective, and about 20% of women will even get pregnant because the condom is not used correctly. Increasing product launches and growing awareness through government initiatives drive the adoption of condoms in the forecast period.

Contraceptives Market, by Product – 2020 and 2028

Contraceptives Market, by Product – 2020 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis:

The North America contraceptives market was valued at US$ 10,433.33 million in 2020 and is projected to reach US$ 15,386.11 million by 2028; it is expected to grow at a CAGR of 5.1% during the forecast period. The North America Contraceptives Market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American contraceptives market in 2020. The growth can be attributed to awareness among the population, prevention of unwanted pregnancies and increasing product developments by key players in the region. Also, rising awareness for sexually transmitted diseases is likely to favor market growth. The growth of the market in the country is primarily driven by increasing awareness for birth control. As per the 2015–2017 National Survey of Family Growth data, in 2015–2017, around 64.9% (46.9 million) of the 72.2 million women aged between 15–49 years in the US were using contraception. It also mentioned the commonly used contraceptive methods were female sterilization (18.6%), oral contraceptive pill (12.6%), long-acting reversible contraceptives (LARCs) (10.3%), and male condom (8.7%). As per the survey female sterilization decreased and use of the pill increased with higher education. Further, also the growing prevalence of sexually transmitted diseases is increasing the demand for contraceptives. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2018, one in five (68 million) people in the US have an STI (sexually transmitted infection) of which 26 million cases were new STIs in 2018. Also, government efforts for family planning is likely to favor the market growth. The government of US has always supported family planning/reproductive health (FP/RH) efforts for more than 50 years and is the largest contributor to family planning/reproductive health across the globe. It is one of the largest distributors and buyer of contraceptives worldwide. The US government funds for FP/RH to the United Nations Population Fund (UNFPA), was US $608 million in the year 2019. Thus, abovementioned factors are expected to propel the contraceptives market growth in North American region.

Key Player Analysis:

The contraceptives market analysis consists of the players such as Bayer AG, Cooper Companies, Inc., Merck & Co., Inc, HLL Lifecare Limited, Church & Dwight, Inc., Pregna International Limited, Mayer Laboratories, Inc., Medicines360, Prosan International B.V., and Cupid Limited. Among the players in the contraceptives Bayer AG and Merck & Co., Inc are the top two players owing to the diversified product portfolio offered.

Recent Developments: 

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the contraceptives market. A few recent key market developments are listed below:

  • In February 2020, Agile Therapeutics, Inc. announced the U.S. Food and Drug Administration's (FDA) approval of Twirla (levonorgestrel and ethinyl estradiol) transdermal system. Twirla is indicated as a contraception for use in women of reproductive potential with a BMI < 30 kg/m2 for whom a combined hormonal contraceptive is appropriate. With this approval, Twirla became the second available contraceptive patch on the market.
  • In February 2022, Organon acquired the rights from Bayer AG to Marvelon and Mercilon, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, including Hong Kong and Macau, and has agreed to acquire the rights to these products in Vietnam.
  • In April 2022, Reckitt Benckiser launched a new condom category, Durex Intense.
  • In July 2021, HRA Pharma received approval from MHRA to launch a contraceptive pill (Desogestrel-only pill), which will be available OTC in the U.K.
  • In March 2021, Cooper acquired a privately held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth, which is expected to provide a contraceptives market opportunity.
  • In December 2021, Cooper Surgical, Inc. acquired Generate Life Sciences. This acquisition helps Cooper to improve their reproductive segment. Generate Life Sciences, a leading provider of donor eggs and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage, for a purchase price of around $1.6 billion.
  • In March 2021, Clue launched a digital contraceptive that offers users a statistical ovulation prediction as a birth control tool. Clue launched Clue Birth Control, an all-digital form of contraceptive that relies on period tracking data. Combining user menstrual cycle data with Clue’s predictive algorithm allows the birth control feature to show which days are high or low risk for pregnancy. Users can then modify their behaviors to accommodate their risk level.
  • In April 2021, Mayne Pharma announced that the U.S. Food and Drug Administration had approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill that contains E4. This naturally occurring oestrogen is now produced from a plant source and has a unique mechanism of action that may offer advantages over other estrogens.
  • In June 2021, Emme, a health tech company that launched a birth control tracking smart case and app, expanded its offerings into prescription delivery and telemedicine. The new EmmeRx expansion means that patients in 16 states can get contraception prescribed and delivered.
  • In August 2020, Cupid Limited, has received USFDA approval for the additional variants of Cupid male contraceptives. The company has received USFDA nod for the additional four variants to market them in the United States. Earlier, the company had received USFDA approval for one variant of male contraceptives.
  • In September 2020, Bureau of Reproductive Health, Department of Health, Ministry of Public Health, and Bayer Thai Co., Ltd., join a collaboration international campaign to reduce unplanned pregnancies among Thai teens as well as promote awareness of effective birth control methods to improve quality of life on World Contraception Day 2020.
  • In August 2018, Luye Pharma Group Ltd. agreed to acquire the global rights to hormonal contraceptive Apleek from Bayer AG. 
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, End User, Distribution Channel

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Bulgaria, Canada, China, Estonia, France, Georgia, Germany, India, Italy, Japan, Lithuania, Mexico, Romania, Saudi Arabia, South Africa, South Korea, Spain, Ukraine, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are Contraceptives?

Contraceptives prevent pregnancy by preventing sperm from entering the uterus. It is more commonly known as the birth control method used to avoid pregnancy. Various contraception is available in the market, such as male condoms, female condoms, IUDs, vaginal rings, diaphragms, and contraceptive sponges. Condoms are the only contraception that prevents sexually transmitted infections (STI).

Who are the major players in the contraceptives market?

The Contraceptives market majorly consists of the players such as Bayer AG, Cooper Companies, Inc., Merck & Co., Inc, HLL Lifecare Limited, Church & Dwight, Inc., Pregna International Limited, Mayer Laboratories, Inc., Medicines360, Prosan International B.V., Cupid Limited. among others.

What are the driving factors for the Contraceptives market across the globe?

The global contraceptives market growth is mainly attributed to factors such increasing rate of unwanted pregnancies, and surge in product innovations and launches fuel the growth of the market. However, lack of adoption in low income countries is the major factor hindering the market growth.

The List of Companies - Contraceptives Market

  • Bayer AG
  • Cooper Companies Inc.
  • Merck & Co. Inc
  • HLL Lifecare Limited
  • Church & Dwight Inc.
  • Pregna International Limited
  • Mayer Laboratories Inc.
  • Medicines360
  • Prosan International B.V.
  • Cupid Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Contraceptives Market